Balyasny Asset Management’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-47,691
| Closed | -$1.21M | – | 1509 |
|
|
2019
Q2 | $1.21M | Sell |
47,691
-15,166
| -24% | -$386K | 0.01% | 889 |
|
|
2019
Q1 | $2.67M | Hold |
62,857
| – | – | 0.02% | 657 |
|
|
2018
Q4 | $915K | Hold |
62,857
| – | – | 0.01% | 830 |
|
|
2018
Q3 | $4.4M | Hold |
62,857
| – | – | 0.02% | 589 |
|
|
2018
Q2 | $4.66M | Hold |
62,857
| – | – | 0.02% | 562 |
|
|
2018
Q1 | $5.98M | Hold |
62,857
| – | – | 0.03% | 558 |
|
|
2017
Q4 | $8.12M | Buy |
62,857
+5,714
| +10% | +$738K | 0.03% | 597 |
|
|
2017
Q3 | $3.88M | Hold |
57,143
| – | – | 0.02% | 655 |
|
|
2017
Q2 | $5.4M | Buy |
+57,143
| New | +$5.4M | 0.02% | 600 |
|
|
2015
Q3 | – | Sell |
-6,575
| Closed | -$4.16M | – | 1223 |
|
|
2015
Q2 | $4.16M | Sell |
6,575
-514
| -7% | -$325K | 0.03% | 464 |
|
|
2015
Q1 | $3.65M | Sell |
7,089
-4,087
| -37% | -$2.1M | 0.03% | 383 |
|
|
2014
Q4 | $5.99M | Buy |
11,176
+10,557
| +1,705% | +$5.65M | 0.06% | 308 |
|
|
2014
Q3 | $927K | Buy |
+619
| New | +$927K | 0.01% | 425 |
|